skip to content

FDA approves the ACTPen for Roche’s Actemra, a single-dose, prefilled autoinjector for the treatment of rheumatoid arthritis, giant cell arteritis and two forms of juvenile arthritis

InvestorsInvestor updates
view all, Investor updates

stay updated

get the latest news and updates to your inbox.